ArticleOncotarget2015

Stroma derived COL6A3 is a potential prognosis marker of colorectal carcinoma revealed by quantitative proteomics.

Jie Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.